Asena Pınar Sefer
Recep Tayyip Erdoğan University
ORCID: 0000-0003-2667-0291Also affiliated with Center for Translational Molecular Medicine, Immune Deficiency Foundation
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 8 papers. Top paper: “Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study”.
Voranush Chongsrisawat, Asena Pınar Sefer, Burcu Kolukısa, Jessica J. Jalbert, Karoline A. Meagher +35 more
Jill M. Fritz, Hayley M. Raquer-McKay, Rhea Kataria, Ivan Vujkovic-Cvijin, Ahmad Al‐Shaibi +29 more
Hassan Abolhassani, Franziska Ober, Başak Kayaoğlu, Sevgi Bilgiç Eltan, Altan Kara +23 more
Mehdi Benamar, Qian Chen, Mehmet Cihangir Çatak, Mónica Martínez‐Blanco, Muyun Wang +16 more
Alexandra Y. Kreins, Mehmet Cihangir Çatak, Royala Babayeva, Baran Erman, Heather Kenney +34 more
Zeynep Meric, Asena Pınar Sefer, Asuman Deveci Özkan, Salim Can, Royala Babayeva +10 more
Dilek Başer, Bengü Akçam, Jeffrey J. Danielson, Sevgi Bilgiç Eltan, Yeşim Haliloğlu +31 more
Durmus Burak Demirkaya, Alper Bulutoglu, Asena Pınar Sefer, Ahmet Ozen, Necmiye Keser Ozturk